BIO 300 Oral Suspension in Discharged COVID-19 Patients Read more about BIO 300 Oral Suspension in Discharged COVID-19 Patients
A Study of Acute Respiratory Infections in Global Outpatient Setting Read more about A Study of Acute Respiratory Infections in Global Outpatient Setting
ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 Read more about ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19
Novel Experimental COVID-19 Therapies Affecting Host Response Read more about Novel Experimental COVID-19 Therapies Affecting Host Response
Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013) Read more about Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)
An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies Read more about An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection Read more about Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection
COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis Read more about COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy Read more about Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy